Wilson's disease: Difference between revisions

(Prepared the page for translation)
 
Line 1: Line 1:
<languages/>
<translate>
==Background==
==Background==
*Autosomal recessive  
*Autosomal recessive  
*Impairment of biliary cellular copper excretion with accumulation in organs (mostly liver, brain, cornea)
*Impairment of biliary cellular copper excretion with accumulation in organs (mostly liver, brain, cornea)
*Liver becomes cirrhotic with ~5% developing liver failure
*Liver becomes cirrhotic with ~5% developing liver failure


==Clinical Features==
==Clinical Features==
[[File:PMC4357635 jbm-22-33-g004.png|thumb|Under slit-lamp test, Kayser-Fleischer ring is evident around the border of cornea (arrow).]]
[[File:PMC4357635 jbm-22-33-g004.png|thumb|Under slit-lamp test, Kayser-Fleischer ring is evident around the border of cornea (arrow).]]
[[File:Kayser-Fleischer ringArrow.jpg|thumb|Another example of Kayser–Fleischer ring (brown ring on the edge of the iris).]]
[[File:Kayser-Fleischer ringArrow.jpg|thumb|Another example of Kayser–Fleischer ring (brown ring on the edge of the iris).]]
Line 10: Line 16:
*Hepatic  
*Hepatic  
**Kayser-Fleischer rings (highly specific)
**Kayser-Fleischer rings (highly specific)
**Asymptomatic (steatosis, chronic hepatitis, compensated [[cirrhosis]])
**Asymptomatic (steatosis, chronic hepatitis, compensated [[Special:MyLanguage/cirrhosis|cirrhosis]])
**[[Abdominal pain]] ([[acute liver failure]]/[[hepatitis]])
**[[Special:MyLanguage/Abdominal pain|Abdominal pain]] ([[Special:MyLanguage/acute liver failure|acute liver failure]]/[[Special:MyLanguage/hepatitis|hepatitis]])
**[[Jaundice]], [[hepatomegaly]], splenomegaly, [[ascites]]
**[[Special:MyLanguage/Jaundice|Jaundice]], [[Special:MyLanguage/hepatomegaly|hepatomegaly]], splenomegaly, [[Special:MyLanguage/ascites|ascites]]
**[[Upper GI bleeding]]; sequela of cirrhosis with varices  
**[[Special:MyLanguage/Upper GI bleeding|Upper GI bleeding]]; sequela of cirrhosis with varices  
*Neurologic symptoms  
*Neurologic symptoms  
**[[Dysarthria]]  
**[[Special:MyLanguage/Dysarthria|Dysarthria]]  
**Gait abnormalities
**Gait abnormalities
**Dystonia
**Dystonia
Line 21: Line 27:
**Parkinsonism  
**Parkinsonism  
*Psychiatric symptoms
*Psychiatric symptoms
**[[Depression]], personality changes, impulsiveness, [[psychosis]]
**[[Special:MyLanguage/Depression|Depression]], personality changes, impulsiveness, [[Special:MyLanguage/psychosis|psychosis]]
 


==Differential Diagnosis==
==Differential Diagnosis==
</translate>
{{Hepatomegaly DDX}}
{{Hepatomegaly DDX}}
<translate>


===Neuro/psychiatric symptoms===
===Neuro/psychiatric symptoms===
*Essential tremor
*Essential tremor
*[[Parkinson's disease]]  
*[[Special:MyLanguage/Parkinson's disease|Parkinson's disease]]  
*Generalized dystonia  
*Generalized dystonia  
*Primary psychiatric disorder (e.g. [[depression]], [[bipolar disorder]], [[schizophrenia]]
*Primary psychiatric disorder (e.g. [[Special:MyLanguage/depression|depression]], [[Special:MyLanguage/bipolar disorder|bipolar disorder]], [[Special:MyLanguage/schizophrenia|schizophrenia]]
*[[Dementia]]
*[[Special:MyLanguage/Dementia|Dementia]]
*Drug abuse
*Drug abuse


==Evaluation==
==Evaluation==
===Workup===
===Workup===
*[[LFTs]] to assess ALT/AST
 
*[[Special:MyLanguage/LFTs|LFTs]] to assess ALT/AST
*CBC to assess for anemia (followed by testing for Coombs-negative hemolytic anemia)
*CBC to assess for anemia (followed by testing for Coombs-negative hemolytic anemia)
*Ocular slit-lamp to assess for Kayser-Flesicher rings  
*Ocular slit-lamp to assess for Kayser-Flesicher rings  


===Diagnosis===
===Diagnosis===
*Outpatient ceruloplasmin concentration, serums copper concentration, 24-hour urinary copper excretion +/- genetic testing can be done to confirm diagnosis
*Outpatient ceruloplasmin concentration, serums copper concentration, 24-hour urinary copper excretion +/- genetic testing can be done to confirm diagnosis


==Management==
==Management==
*Potent chelators: D-penicillamine (first-line), trientine (second-line), oral zinc  
*Potent chelators: D-penicillamine (first-line), trientine (second-line), oral zinc  
*Low-copper diet  
*Low-copper diet  


==Disposition==
==Disposition==
*Hepatology consult should be made for follow up
*Hepatology consult should be made for follow up
**Screening for hepatocellular carcinoma (HCC) recommended but unclear association  
**Screening for hepatocellular carcinoma (HCC) recommended but unclear association  


==See Also==
==See Also==


==External Links==
==External Links==


==References==
==References==
#Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184:173.
#Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184:173.
#Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28 Suppl 1:28.
#Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28 Suppl 1:28.
Line 62: Line 88:


[[Category:GI]]
[[Category:GI]]
</translate>

Latest revision as of 00:04, 5 January 2026


Background

  • Autosomal recessive
  • Impairment of biliary cellular copper excretion with accumulation in organs (mostly liver, brain, cornea)
  • Liver becomes cirrhotic with ~5% developing liver failure


Clinical Features

Under slit-lamp test, Kayser-Fleischer ring is evident around the border of cornea (arrow).
Another example of Kayser–Fleischer ring (brown ring on the edge of the iris).
Copper deposition on corneal Descemet's membrane on slit lamp exam.


Differential Diagnosis

Hepatic Dysfunction

Infectious

Neoplastic

Metabolic

Biliary

  • Biliary cirrhosis

Drugs

Miscellaneous


Neuro/psychiatric symptoms


Evaluation

Workup

  • LFTs to assess ALT/AST
  • CBC to assess for anemia (followed by testing for Coombs-negative hemolytic anemia)
  • Ocular slit-lamp to assess for Kayser-Flesicher rings


Diagnosis

  • Outpatient ceruloplasmin concentration, serums copper concentration, 24-hour urinary copper excretion +/- genetic testing can be done to confirm diagnosis


Management

  • Potent chelators: D-penicillamine (first-line), trientine (second-line), oral zinc
  • Low-copper diet


Disposition

  • Hepatology consult should be made for follow up
    • Screening for hepatocellular carcinoma (HCC) recommended but unclear association


See Also

External Links

References

  1. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184:173.
  2. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28 Suppl 1:28.
  3. Soltanzadeh A, Soltanzadeh P, Nafissi S, et al. Wilson's disease: a great masquerader. Eur Neurol 2007; 57:80.
  4. Stremmel W, Meyerrose KW, Niederau C, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115:720.
  1. Tintanelli's